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Purpose: Apoptosis is known to play a key role in cell death after retinal ischemia. However, little is known about the
kinetics of the signaling pathways involved and their contribution to this process. The aim of this study was to determine
whether changes in the expression of molecules in the mitochondrial apoptotic pathway might explain the progression of
retinal damage following ischemia/reperfusion.
Methods: Retinal ischemia was induced by elevating intraocular pressure in the vitreous cavity to 150 mmHg for a period
of 60 min. At time 0, 3 h (early phase), and 24 h (late phase) after reperfusion, the retinas were harvested and modifications
in the expression of Bax, Bak, Bcl-2, and Bcl-xL as well as caspase-3 and −7, were examined by qPCR and, in some cases,
by western blot.
Results: qPCR analysis performed at the early phase after ischemia revealed a time dependent decrease in Bax, Bak, and
Bcl-xL and no alteration in Bcl-2 mRNA expression in response to retinal ischemia. At the protein level, proapoptotic Bax
and Bak were not modulated while Bcl-2 and Bcl-xL were significantly upregulated. At this stage, the Bax per Bcl-2 and
Bax:Bcl-xL ratios were not modified. At the late phase of recovery, Bax and Bcl-xL mRNAs were downregulated while Bak
was increased. Increased Bax:Bcl-2 and Bax:Bcl-xL ratios at both the mRNA and protein levels were observed 24 h after
the ischemic insult. Analysis of caspases associated with mitochondria-mediated apoptosis revealed a specific increase in
the expression of caspase-3 in the ischemic retinas 24 h after reperfusion, and a decrease in the expression of caspase-7.
Conclusions: This study revealed that Bcl-2-related family members were differently regulated in the early and late phases
after an ischemic insult. We showed that the Bax:Bcl-2 and Bax:Bcl-xL balances were not affected in the initial phases,
but the Bax:Bcl-xL ratio shifted toward apoptosis during the late phase of recovery. This shift was reinforced by caspase-3
upregulation.
Retinal cell death induced by transient ischemia occurs
through necrosis and apoptosis. The latter has been widely
studied. TUNEL staining has revealed that apoptotic cells can
be observed as early as 3 h after the ischemic insult and that
their number progressively increased and reached a plateau at
24 h [1-3]. These cells are mainly located in the ganglion cell
layer, the inner nuclear layer, and, to a lesser extent, the outer
nuclear layer [1,2]. In the case of moderate retinal ischemia,
as in experimental branch vein occlusion, apoptosis has also
been observed at peripheral retinal areas and has been
associated with diffuse edema of the inner nuclear layer [4].
The mechanisms underlying apoptosis following
ischemia/reperfusion (I/R) have been extensively studied.
Special attention has been given to the mitochondria-mediated
apoptotic pathways, in particular to the Bcl-2 family
members, which are important regulators of cell death in the
brain, heart, liver, kidney, and retina [5-9]. This family of
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proteins is divided into proapoptotic members, including Bax,
Bak, and Bcl-2 homology domain 3 (BH3)-only proteins (i.e.,
Bad, Puma, and Noxa) and antiapoptotic members, such as
Bcl-2 and Bcl-xL. In a nonapoptotic environment, Bax is
maintained in the cytosol, sequestered by the antiapoptotic
Bcl-2 and Bcl-xL [10]. When stimulated, Bax is activated and
translocated to the mitochondria, where it forms pores in the
outer membrane by binding with the adenine nucleotide
translocator leading to permeabilization of the mitochondria
[11-13]. This in turn initiates cytochrome C release from the
mitochondria and activates the Apaf-1–caspase-9 apoptosome
and downstream effector caspases [14].
Increased Bax and decreased Bcl-2 expressions have been
described in several models of cerebral ischemia, and a
reduction in antiapoptotic Bcl-xL mRNA following traumatic
brain injury has also been reported [15-18]. These studies
suggest that an imbalance in the regulation between pro- and
antiapoptotic molecules triggers apoptosis. Similar studies
were performed on the retina but, excepting the consensus
observation that Bax expression was upregulated following an
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ischemic insult, conflicting results were obtained for Bcl-2
regulation [1,19-21].
Clarification of the mechanisms involved in retinal
ischemia, and a better understanding of potential similarities
between brain and retinal injury following an ischemic insult,
would serve to accelerate the development of therapies. The
aim of this study is, therefore, to unravel the sequential
modulation of members of the Bcl-2 family following I/R in
the retina.
METHODS
Animal handling and surgery: All experimental procedures
involving rats were performed in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the local Committee Office
on Use and Care of Animals in Research of the State of Valais,
Sion, Switzerland.
The procedure to induce transient ischemia followed by
reperfusion has already been described [22]. In brief, 250–300
g male Sprague-Dawley rats, purchased from Janvier (Le
Genest-St-Isle, France), were first anesthetized by isoflurane
inhalation and then by intraperitoneal injection of a freshly
made mixture of 100 mg/kg ketamine hydrochloride and
10 mg/kg xylazine hydrochloride. Rat pupils were dilated with
0.5% atropine drops, and corneas were anesthetized with 2
drops of 0.4% oxybuprocain. During the whole procedure, rats
temperature was monitored and maintained at 37 °C. A steel
30-gauge infusion needle (Becton Dickinson, Basel,
Switzerland) connected to a saline reservoir was inserted into
the vitreous cavity of the left eye. The pressure was elevated
to 150 mmHg for a period of 1 h. Retinal and choroidal
bloodstream arrest was immediately observed under the
binocular microscope Stemmi 2000-C (Zeiss, Feldbach,
Switzerland). After 60 min of ischemia, the pressure was
restored to normal levels by removing the needle and the
perfusion immediately resumed. The integrity of the retinal
blood flow was observed with the operating binocular
microscope both before and after the procedure.
Animals were divided into a control and an I/R group.
The control group was divided into two subgroups: anesthesia
only; and sham-operated, which was done by inserting a
needle into the vitreous cavity of the rat’s left eye without
causing elevation of the intraocular pressure (IOP). In the I/R
group, the needle was inserted into the vitreous cavity of the
left eye and the pressure increased. At 3 or 24 h after
reperfusion the rats were anesthetized with isoflurane and
euthanized with an intraperitoneal administration of an
overdose of 150 mg/kg bodyweight sodium pentobarbital
(Escarnakon; Streuli Pharma SA, Uznach, Switzerland). Both
eyes were enucleated and the retinas carefully dissected.
RNA isolation: The retinas were dissected under a binocular
microscope to exclude extraretinal tissues, then rapidly
isolated in RNAlater (Ambion; Applied Biosystems,
Rotkreuz, Switzerland) before being transferred to TRIzol
reagent (Invitrogen AG, Basel, Switzerland) and stored at
−80 °C until RNA extraction. Total RNA was extracted
following the manufacturer’s instructions. Both quantity and
quality of RNA were determined on a ND-1000
spectrophotometer (NanoDrop technologies, Inc.,
Wilmington, DE).
Quantitative reverse transcription-PCR: cDNA synthesis
was performed using 2 μg of total RNA in 20 μl reaction
volume. This was done using an oligo dT primer according to
the manufacturer’s manual (Affinity Script; Stratagene;
Agilent technologies SA, Morges, Switzerland). The
equivalent of 12.5 ng of original total RNA was used for
quantitative PCR amplification using the 2× brilliant SYBR
Green QPCR Master Mix (Stratagene; Agilent technologies
SA, Morges, Switzerland). One μM forward and reverse
primers, designed to span an intron of the target gene were
TABLE 1. PRIMERS FOR QUANTITATIVE PCR
Gene (GenBank accession number) Primers (5′-3′) Size (bp)
Bax (NM_017059) F: GAGCGGCTGCTTGTCTGGAT 161
R: CAAGGCAGCAGGAAGCCTCA
Bak (NM_053812) F: AATGGCATCCGGACAAGGAC 135
R: TGTTCCTGCTGGTGGAGGTA
Bcl-2 (NM_016993) F: CTGAACCGGCATCTGCACAC 195
R: GCAGGTCTGCTGACCTCACT
Bcl-xL (NM_001033670) F: GGTCGCATTGTGGCCTTCTT 196
R: CTCTCGGCTGCTGCATTGTT
Casp 3 (NM_012922) F: GACTGCGGTATTGAGACAGA 209
R: CGAGTGAGGATGTGCATGAA
Casp 7 (NM_022260) F: CAACGACACCGACGCTAATC 161
R: GGTCCTTGCCATGCTCATTC
Actin-β (NM_031144) F: AGGCCAACCGTGAAAAGATG 100
R: ACCAGAGGCATACAGGGACAA
This table gives accession number, primers sequence for quantitative PCR and amplicon size.
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added to the mix. Table 1 gives the sequence of the primers
used in this study. Real-time PCR was performed in a
Mx3000PTM system (Stratagene) with the following cycling
conditions: 40 cycles of denaturation at 95 °C for 30 s,
annealing at 59 °C for 30 s, and extension at 72 °C for 30 s.
Samples were amplified in triplicate, and data were
normalized with expression of β-actin.
Western blot analysis: The retinas were rapidly dissected in
1× phosphate-buffered saline (PBS; NaCl 137 mM, KCl
2.7 mM, Na2HPO4 10 mM, KH2PO4 1.75 mM, pH 7.4)
Figure 1. Ischemia reduced Bax, Bak, and Bcl-xL mRNAs expression
3 h after I/R. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL (D) mRNAs
expression was measured by qPCR 3 h after reperfusion. At 3 h after
reperfusion, ischemia decreased Bax (A), Bak (B), and Bcl-xL (D)
expression but did not alter the Bcl-2 mRNA level (C). E and F
showed no modification in Bax:Bcl-2 nor Bax:Bcl-xL mRNA ratios
in the early phase after I/R. Brown columns denote control retinas
(n=6), and beige columns denote ischemic retinas (n=10). Error bars
represent SEM, where *p<0.05, ***p<0.001 in control versus
ischemic retinas as measured by Student's t-test.
supplemented with a 1× protease inhibitor cocktail (Roche
Applied Science, Basel, Switzerland). Retinas were then
transferred to a Hepes-Tween solution, which contained
20 mM Hepes and 0.5% Tween-20, and included 1×
phosphatase and 1× protease inhibitor cocktails (Sigma-
Aldrich, Basel, Switzerland), before they were stored at
−80 °C until protein extraction. Samples were frozen and
thawed three times, then homogenized on ice. Supernatant
was collected after 30 min of centrifugation at 9.3 xg at 4 °C.
The amount of protein was determined using a bicinchoninic
acid (BCA) protein assay kit (Pierce Biotechnology,
Rockford, IL). As loading control, β-actin was measured in
each western blot. Protein samples were run on 12% SDS–
PAGE and transferred to a polyvinylidene fluoride membrane
(Whatman; Schleicher and Schuell, St. Marcel, France) for 1
h at 4 °C. Membranes were then blocked at room temperature
for 1 h in 1× tris-buffered saline (TBS; NaCl 137 mM, TRIS
25 mM, pH 7.4) and 0.1% Tween-20 and incubated with the
appropriate antibody overnight at 4 °C. Antibodies were
diluted in 1× TBS and 0.1% Tween-20 containing 2%
blocking reagent (ECL Advanced; Amersham Biosciences,
Otelfingen, Switzerland). Next, 1:1,000 rabbit anti-Bcl-2
(#2876), 1:1,000 anti-Bcl-xL (#2764), and 1:1,000 anti-Bak
(#3814) were obtained from Cell Signaling Technology
(Bioconcept, Alschwill, Switzerland), rabbit anti-Bax (#493)
from Santa Cruz Biotechnology (LabForce AG, Nunnigen,
Switzerland) and 1:10,000 mouse anti-β-actin (#A5441) from
(Sigma-Aldrich, Basel, Switzerland). Detection was
performed with horseradish peroxidase-conjugated secondary
antibodies (Amersham Biosciences; Otelfingen, Switzerland)
and visualized by enhanced chemiluminescence (Millipore
Corporation, Billerica, MA,) on a luminescent image analyzer
(LAS 4000mini; Bucher Biotech, Basel, Switzerland).
Quantification analysis of the proteins was performed with
Multigauge (Fujifilm) software.
Statistics: Results are presented as mean ±standard error of
the mean (SEM) of the indicated number of independent
experiments. Statistical analysis was performed using the
Student’s t-test. Differences were considered significant for
p<0.05.
RESULTS
To unravel the mechanisms involved in the apoptotic process
induced after retinal ischemia, we assessed whether members
of the Bcl-2 family of genes were regulated early (3 h) or late
(24 h) after I/R, both at the mRNA and protein levels. As our
preliminary experiments indicated that both anesthesia and
sham-insertion of a needle in the vitreous cavity were
associated with modulation of several of the genes
investigated, we compared each measurement with values
from sham-operated rats set to 1.
Early modulation at mRNA level: Three hours after I/R,
the following proapoptotic Bax (0.679±0.058, p<0.05) and
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Bak mRNAs (0.600±0.033, p<0.001), as well as the
antiapoptotic Bcl-xL (0.768±0.047, p<0.05) were significantly
downregulated. The antiapoptotic Bcl-2 did not change
(0.868±0.169; Figure 1A-D). Rather than individual gene
alteration, it is the ratio between pro- and antiapoptotic
members that is responsible for cell fate. We therefore
calculated the Bax:Bcl2 and Bax:Bcl-xL ratios in each retina,
but neither ratio showed any alteration 3 h after I/R
(0.940±0.205 and 0.996±0.113, respectively; Figure 1E-F).
Early modulation at protein level: At the protein level,
Bcl-2 and Bcl-xL increased 3 h after I/R (1.446±0.163, and
1.697±0.294, respectively) while Bax and Bak levels
increased slightly but not significantly (1.171±0.136,
1.769±0.531; Figure 2A-D). As for mRNA, the Bax:Bcl-2 and
Bax:Bcl-xL protein ratios did not reveal any modulation
(1.144±0.238 and 0.970±0.129, respectively; Figure 2E-F).
Late modulation at mRNA level:: Analyses 24 h post I/R
revealed that Bax and Bcl-xL were downregulated
(0.841±0.033, p<0.05, and 0.604±0.025, p<0.01,
respectively) while Bak was upregulated (1.478±0.052,
p<0.001; Figure 3A-B,D). The strong decline of Bcl-xL was
further amplified in the Bax:Bcl-xL ratio (1.446±0.106;
Figure 2. Ischemia did not modify proapoptotic but increased antiapoptotic proteins 3 h after I/R. Effect of ischemia 3 h after reperfusion on
Bax (A), Bak (B), Bcl-2 (C), Bcl-xL (D) protein levels measured by western blot. In (E-F) no modification in Bax/Bcl-2 nor Bax/Bcl-xL protein
ratios were observed at this time. Brown columns denote control retinas (n=6–10), and beige columns denote ischemic retinas (n=8–12). Error
bars represent SEM, where *p<0.05 in control versus ischemic retinas as measured by Student's t-test.
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p<0.005; Figure 3F) Bcl-2 was not significantly modulated
(0.759±0.116), nor was the Bax:Bcl-2 ratio (1.194±0.132,
Figure 3C,E).
Late modulation at protein level: Contrary to mRNA,
Bax and Bcl-xL protein levels were significantly upregulated
24 h post I/R (1.511±0.148 and 1.402±0.188, p<0.05,
respectively). The strong upregulation seen for Bak at the
mRNA level was not present at the protein level
Figure 3. mRNA levels of Bak increased and Bcl-xL decreased 24 h
after I/R. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL (D) mRNAs
expression was measured by qPCR 24 h after reperfusion. Twenty-
four h after reperfusion, ischemia induced a slight decrease in Bax
(A), and strongly increase Bak (B) mRNA expression. Anti-apoptotic
Bcl-2 expression (C) was not modified, but Bcl-xL (D) was strongly
reduced 24 h after I/R. Figure 1 E,F revealed no modification in
Bax:Bcl-2 and a highly significant increase in Bax:Bcl-xL mRNAs
ratio 24 h after I/R. Brown columns denote control retinas (n=6), and
beige columns denote ischemic retinas (n=10). Error bars represent
SEM, where *p<0.05, **p<0.005, ***p<0.001 in control versus
ischemic retinas as measured by Student's t-test.
(1.270±0.177). Bcl-2 protein did not change significantly
(1.447±0.217). The shift of balance toward apoptosis was also
evident on the Bax:Bcl-2 and Bax:Bcl-xL ratios (1.463±0.216,
1.340±0.165; p<0.05; Figure 4A-F).
We then focused on the kinetics of the response and
compared the modulation of the Bcl-2 family members
between the early (3 h) and late (24 h) phases post I/R. Bax
expression significantly increased by about 30% both at the
mRNA (1.325±0.044) and protein levels (1.383±0.135), while
Bcl-xL decreased by about 20% at the mRNA (0.787±0.033)
and protein levels (0.826±0.106). Bak was upregulated at the
mRNA level (2.462±0.103) but this was not confirmed at the
protein level (0.717±0.387). Here again, these seemingly
small modifications of expression were further amplified
when the Bax:Bcl-xL ratio was analyzed, and a strong shift of
the pro- and antiapoptotic balance toward apoptosis was
observed. Interestingly, Bcl-2 did not seem to be involved in
the kinetics of the response to I/R because it did not change
significantly (Figure 5).
Ischemia-induced caspase-3 and repressed caspase-7
mRNAs expression 24 h after I/R: To further investigate the
impact of retinal ischemia on downstream effectors of
apoptosis stimulated by members of the Bcl-2 family, we
analyzed the expression of caspase-3 and caspase-7 by qPCR.
In the early recovering phase, caspase-3 did not change
(1.147±0.077) and caspase-7 was downregulated
(0.646±0.052). At 24 h post I/R, caspase-7 was further
reduced (0.536±0.025, p<0.005) while caspase-3 was
upregulated (1.656±0.141, p<0.05) (Figure 6A-D). Kinetics
analysis of caspase regulation revealed a strong increase in
caspase-3 expression (1.494±0.128, p<0.005) and no
modulation of caspase-7 (0.830±0.039; Figure 6E-F).
DISCUSSION
Artificial IOP increase is a recognized model of retinal
ischemia and is accompanied by apoptosis. We and other
researchers have observed in this model that the number of
dying cells increases from 3 h (early) until 24 h (late) after I/
R [3]. In this study, we analyzed the response of several
Bcl-2-related genes in an early and late period following I/R.
We first considered the regulation of several Bcl-2 family
genes at time 0, 3, and 24 h in control retinas from anesthetized
animals and from anesthetized animals in which a needle had
been inserted and kept in place for 1 h, but without initiating
any increase in IOP. We observed that the sole insertion of a
needle triggered upregulation of several genes. Therefore, and
to specifically track the changes induced by ischemia rather
than by anesthesia or needle insertion, we compared gene
regulation between ischemic and needle inserted-only retinas.
Our results showed a dysregulation between pro- and
antiapoptotic genes resulting in a proapoptotic signaling
cascade in ischemic retinas. This underlined the importance
of a time-related upregulation of the proapoptotic Bax and did
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not support a relevant role for Bak in this deleterious process.
The injury is mostly due to Bcl-xL downregulation rather than
downregulation in Bcl-2 expression. Although slight
differences between mRNA and protein regulation were
obtained in ischemic and control retinas, Bax:Bcl-2 and
Bax:Bcl-xL ratios were similarly modulated over time.
Upregulation of Bax at the protein level is in agreement with
in vitro and in vivo studies of retinal ischemia [1,19-21] as
well as observations made after cerebral ischemia [15-17].
However, we demonstrated that Bax mRNA and protein
increase is time dependent, suggesting a delayed role for this
gene in the apoptotic process induced by I/R.
The regulation of Bcl-2 has widely been considered in the
study of the retina as well as in cerebral ischemia. In the central
nervous system, however, the role of Bcl-2 in response to
neuronal injury is unclear because both increases and
decreases in Bcl-2 levels have been described. In vitro, a
decrease in the expression of Bcl-2 has been reported in
Figure 4. Ischemia induced a protein imbalance toward apoptosis 24 h after the ischemic insult. Bax (A), Bak (B), Bcl-2 (C), and Bcl-xL
(D) protein levels were measured by western blot 24 h after I/R. At this time proapoptotic Bax was significantly increased (A), but there was
no modification in Bak (B). No modification in Bcl-2 (C) and an increase in Bcl-xL (D) protein levels were observed 24 h after reperfusion. In
E and F, a significant increase in Bax:Bcl-2 and Bax:Bcl-xL protein ratios were measured at this time. Brown columns denote control retinas
(n=6–10) and beige columns denote ischemic retinas (n=8–12). Error bars represent SEM, where *p<0.05, **p<0.005 in control versus
ischemic retinas as measured by Student's t-test.
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cultured retinal cells stimulated by various means, including
simulated ischemia and excitotoxicity [19], whereas no
obvious change in Bcl-2 gene expression was observed in vivo
in retinas where ischemia was induced by increased IOP [1].
In another report, retinal ischemia was shown to induce an
initial decrease in Bcl-2 mRNA expression followed by a later
increase in its expression [21]. The discrepancies of the results
reported on Bcl-2 expression are reinforced by the observation
that Bcl-2 peptide administration did not increase retinal
ganglion cell survival after optic nerve section but did so after
selective ligature of the ophthalmic vessels [23]. Clearly,
Bcl-2 involvement is not identical in these different models.
In our study, we showed an increase of this protein during the
early phase following I/R, after which its level remained
constant until at least 24 h. This observation is in accordance
with the results obtained by Kaneda et al. [1] at the mRNA
level.
Bcl-2 has also been assessed in the experimental model
of glaucoma after hypertonic saline injection [24]. In this
study, the increase of apoptosis in retinal ganglion cells was
linked to a downregulation of the Bcl-2:Bax ratio. However,
this decrease was associated with a marked reduction in Bcl-2
rather than with an increase in Bax itself [24]. The difference
in the role of Bcl-2 in our study could result from the
experimental model and from the duration of the experiment.
Furthermore, our results do not exclude Bcl-2 downregulation
after 24 h.
A mRNA study of Bcl-xL regulation after I/R revealed that
it was slightly but significantly downregulated in comparison
to sham-operated retinas. Consistent with mRNA and protein
regulation was the time-dependent downregulation of Bcl-
xL. Our results are in agreement with the moderate decrease in
Bcl-xL mRNA expression in the retina observed after optic
nerve crush [25]. The observation that Bcl-xL is the
predominant Bcl-2 family member expressed in the retina
supports the concept that the neural retina has a pattern of
Bcl-2 expression similar to that of other central neurons [25,
26]. This suggests that modification in Bcl-xL expression after
I/R in the retina could be identical to that following cerebral
ischemia. However, our results showing a time-related
decrease in Bcl-xL expression in the retina following I/R are
in conflict with a publication on hippocampal neurons, where
no alteration of the abundance of Bcl-xL was observed
following I/R [27].
The observation that neither the Bax:Bcl-2 nor the
Bax:Bcl-xL ratios are regulated at a time when apoptosis is
already detectable (3 h) suggests that Bcl-2-related family
members are not associated with early cell death following I/
R. However, the number of apoptotic cells may not be
sufficient to allow for an accurate reading of the contribution
of Bcl-2 family members. An alternative explanation could be
that apoptosis is triggered not by an increase in Bax expression
but by its translocation to the mitochondria, as has been
demonstrated in a central retinal artery occlusion model of
retinal ischemia [2]. More investigations regarding the
activity of Bax are needed to attest Bcl-2 involvement in the
deleterious effect induced by an ischemic insult of the retina.
Bak, another member of the Bcl-2 family, has been shown
to change its intracellular location early in the promotion of
apoptosis [28]. In comparison to Bax- or Bak-deficient mice,
Bax and Bak double knockout mice displayed multiple
developmental defects, including an accumulation of excess
cells within the central nervous system. This indicated that
both Bax and Bak have overlapping roles in the regulation of
apoptosis during mammalian development and tissue
Figure 5. Bcl-2 family members are similarly regulated at the mRNA and protein levels. Ischemia modified Bax, Bak, Bcl-2, and Bcl-xL
mRNA (A) and protein expression (B) 24 h after reperfusion relative to 3 h. A: Proapototic Bax and Bak mRNAs expression was increased,
whereas antiapoptotic Bcl-xL was decreased and Bcl-2 expression unaltered 24 h after I/R. B: At the protein level, Bax expression was
significantly increased but there was no modification in Bak, Bcl-2, or Bcl-xL when measured 24 h after I/R. Green columns mark ischemic/
ctrl ratio (i/c) ratio at 3 h, and light blue columns indicate i/c ratio at 24 h. Error bars represent SEM, where *p<0.05, ***p<0.001 in control
versus ischemic retinas as measured by Student's t-test.
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homeostasis [29]. In the same way, Bax and Bak double
knockout cells showed resistance to apoptosis induced by
various stimuli, demonstrating the crucial role of these
Figure 6. Ischemia induced caspase-3 and repressed caspase-7
mRNAs expression 24 h after reperfusion. Caspase-3 (A-C) and
caspase-7 (B-D) mRNAs expression was measured by qPCR 3 h
(A-B) and 24 h (C-D) after reperfusion. A-B: No change in caspase-3
(A) or caspase-7 (B) was observed 3 h after I/R. C-D: Ischemia
induced a significant increase in caspase-3 (C) and decrease in
caspase-7 (D) mRNA 24 h following the ischemic insult. E:
Ischemic/ctrl ratio (i/c) mRNA ratios reported an important increase
in caspase-3 and no changes in caspase-7 between 3 and 24 h after
I/R. Brown columns mark control retinas (n=6–10), and beige
columns denote ischemic retinas (n=8–12). Green columns represent
i/c ratio at 3 h, and light blue columns indicate i/c ratio at 24 h. Error
bars represent SEM, where *p<0.05, **p<0.005 in control versus
ischemic retinas, and #p<0.01 ischemic retinas at 3 h versus 24 h as
measured by Student's t-test.
proteins in the regulation of cell death [11]. However, a 2006
study underlined the role of Bax and Bak in the regulation of
mitochondrial dynamics in healthy cells and indicated that
Bcl-2 family members may also regulate apoptosis through
organelle morphogenesis [30]. Bax and Bak were also
reported to act as essential components of the unfolded protein
response. Although this role is independent of their
proapoptotic function, it appeared that Bax and Bak might act
as stress sentinels that connect stress signals to the
proapoptotic core when cellular homeostasis is irreversibly
altered [31].
As these different studies support a major role for Bak in
the regulation of apoptosis, we also analyzed its expression
by quantitative PCR and western blot. Surprisingly, our
results showed that Bak regulation does not play a
fundamental role in apoptosis following retinal ischemia.
Indeed, even if its mRNA expression was time-dependently
regulated, the observation that it was not altered by the
ischemic insult at the protein level suggested that Bak level
was not crucial to the apoptotic event following I/R at the time
studied. However, the analysis of Bak expression later than
24 h after I/R could also reveal an important role of this
protein. Furthermore, the absence of Bak protein regulation
did not exclude that its apoptotic effect could be induced by
its translocation rather than by its regulation after I/R, but this
remains to be demonstrated [28].
Bax and Bak activation, opening of the mitochondrial
permeability transition pore (mPTP), and cell death have been
reported to be mediated through Bcl-2/adenovirus E1B
19 kDa protein-interacting protein 3 (Bnip3), a BH3-only
protein localized primarily in mitochondria [32-34], although
this is still controversial [35]. In a model of myocardial
ischemia and reperfusion, Bnip3 was reported as a
mitochondrial sensor of oxidative stress [36], thus
contributing to cell death during I/R in ex vivo-perfused hearts
and in cell culture [37,38]. Therefore, it would be interesting
to study Bnip3-induced activation of Bax and Bak and to
analyze whether Bnip-3 could also be associated with the
increase in apoptosis observed after I/R in the retina.
However, preliminary results more readily suggest a decrease
in Bnip-3 expression after I/R. Bellot et al. very recently
demonstrated that hypoxia induced autophagy via Bnip-3 and
that Bnip-3L was clearly a survival mechanism [39].
However, these observations were not in accordance with
Puyal et al. [40], whose work revealed that cerebral
postischemic autophagy inhibition was neuroprotective.
Further studies are needed to resolve this issue and to
determine the proapoptotic or prosurvival action of Bnip-3
expression.
We also showed that caspase mRNA was specifically
modulated by ischemia, as we reported a time-related increase
in caspase-3 and decrease in caspase-7. Caspase-3, a well
known apoptosis effector, has been studied in several models
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of retinal ischemia, including IOP elevation [41-43] and
axotomy [44-46]. Caspase-7, which is structurally and
functionally similar to caspase-3, has been shown to
compensate for the lack of caspase-3 [47,48]. Therefore, it
seems likely that the absence of caspase-7 upregulation is a
consequence of the regulation of caspase-3.
In summary, the current study reports a novel regulation
of Bcl-2-related family members following retinal ischemia.
It clearly finds an association with an increase in Bax with a
decrease in Bcl-xL expression and negates any involvement of
Bak and Bcl-2 regulations in the damage induced by retinal
ischemia 24 h after reperfusion. It also links caspase-3 to the
deleterious effect induced by the elevation of IOP. Finally,
although further investigations will be necessary to unravel
the exact mechanism involved following I/R, this study
highlights the importance of mitochondrial mediation of the
apoptotic pathway in the deleterious effects in this model.
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